Risk Factors for Empiric Treatment Failure in US Female Outpatients with Uncomplicated Urinary Tract Infection: an Observational Study.

Autor: Fromer DL; Urology, Hackensack University Medical Center, Hackensack, NJ, USA., Luck ME; US Medical Affairs, GSK, Collegeville, PA, USA., Cheng WY; Health Economics and Outcomes Research, Analysis Group, Inc., Boston, MA, USA., Mahendran M; Health Economics and Outcomes Research, Analysis Group, Inc., Boston, MA, USA., da Costa WL; Health Economics and Outcomes Research, Analysis Group, Inc., Boston, MA, USA., Pinaire M; Health Economics and Outcomes Research, Analysis Group, Inc., Boston, MA, USA., Duh MS; Health Economics and Outcomes Research, Analysis Group, Inc., Boston, MA, USA., Preib MT; Global VEO, GSK, Collegeville, PA, USA., Ellis JJ; US VEO, GSK, Collegeville, PA, USA. jeffrey.x.ellis@gsk.com.

Publikováno v: Journal of general internal medicine [J Gen Intern Med] 2024 Oct 02. Date of Electronic Publication: 2024 Oct 02.

Assessing the use of anti-PD1 monotherapy as adjuvant therapy and determinants of treatment choice in stage III cutaneous melanoma in the US.

Autor: Whitman ED; Atlantic Health System Cancer Care, Morristown, NJ, USA.; Atlantic Melanoma Center, Morristown, NJ, USA., Totev TI; Analysis Group, Inc., Boston, MA, USA. todor.totev@analysisgroup.com., Jiang S; Merck and Co., Inc., Rahway, NJ, USA., da Costa WL Jr; Analysis Group, Inc., Boston, MA, USA., Grebennik D; Merck and Co., Inc., Rahway, NJ, USA., Wang H; Analysis Group, Inc., Boston, MA, USA., Boca AE; Analysis Group, Inc., Boston, MA, USA., Ayyagari R; Analysis Group, Inc., Boston, MA, USA.

Publikováno v: BMC cancer [BMC Cancer] 2024 Mar 27; Vol. 24 (1), pp. 389. Date of Electronic Publication: 2024 Mar 27.

Bayesian Approach to Understand the Association Between Treatment Down-staging and Survival for Patients With Pancreatic Adenocarcinoma.

Autor: da Costa WL Jr; Department of Medicine, Epidemiology, and Population Sciences, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Tran Cao HS; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Gu X; Department of Medicine, Epidemiology, and Population Sciences, Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX., Massarweh NN; Atlanta VA Health Care System, Decatur, GA.; Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine, Atlanta, GA.; Department of Surgery, Morehouse School of Medicine, Atlanta, GA.

Publikováno v: Annals of surgery [Ann Surg] 2022 Mar 01; Vol. 275 (3), pp. 415-421.

Survival outcomes of patients with pathological stage I gastric cancer using the competing risks survival method

Autor: de Farias Ic, Coimbra Fjf, da Costa Wl, Felismino Tc, de Jesus Vhf, de Castro Ribeiro Hs, de Godoy Al, Diniz Al, Calsavara Vf

Publikováno v: Journal of Gastrointestinal Oncology. 10:1110-1119

Background: Patients with stage I gastric cancer are considered to have an exquisite prognosis. Nonetheless, the fact that some patients experience disease relapse highlights that a subgroup might benefit from multimodality treatment. We aimed to eva

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a6a65f06f0dcc37389671d441415d25
https://doi.org/10.21037/jgo.2019.10.04

Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems.

Autor: Li A; Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX., La J; Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA., May SB; Institute for Clinical & Translational Research, Baylor College of Medicine, Houston, TX., Guffey D; Institute for Clinical & Translational Research, Baylor College of Medicine, Houston, TX., da Costa WL Jr; Section of Epidemiology and Population Science, Baylor College of Medicine, Houston, TX., Amos CI; Institute for Clinical & Translational Research, Baylor College of Medicine, Houston, TX.; Section of Epidemiology and Population Science, Baylor College of Medicine, Houston, TX., Bandyo R; Harris Health System, Houston, TX., Milner EM; School of Medicine, Baylor College of Medicine, Houston, TX., Kurian KM; School of Medicine, Baylor College of Medicine, Houston, TX., Chen DCR; Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA.; Section of General Internal Medicine, Boston University School of Medicine, Boston, MA., Do NV; Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA.; Section of General Internal Medicine, Boston University School of Medicine, Boston, MA., Granada C; Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX., Riaz N; Section of Hematology-Oncology, Baylor College of Medicine, Houston, TX., Brophy MT; Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA.; Section of Hematology & Medical Oncology, Boston University School of Medicine, Boston, MA., Chitalia V; Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA.; Renal Section, Department of Medicine, Boston University School of Medicine, Boston, MA.; Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA., Gaziano JM; Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Division of Aging, Brigham and Women's Hospital, Boston, MA., Garcia DA; Division of Hematology, University of Washington School of Medicine, Seattle, WA., Carrier M; Department of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada., Flowers CR; Division of Cancer Medicine, Department of Lymphoma-Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Zakai NA; Departments of Medicine and Pathology and Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT., Fillmore NR; Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA.; Section of Hematology & Medical Oncology, Boston University School of Medicine, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jun 01; Vol. 41 (16), pp. 2926-2938. Date of Electronic Publication: 2023 Jan 10.